Remove Clinic Remove Diagnose Remove Disease Remove Events
article thumbnail

Beware risk of adverse events associated with GBCAs

AuntMinnie

To make the situation more complicated, not all possible adverse events from GBCAs are noted in drug packaging, wrote a team led by Lu Wang , PhD, of Yantai Yuhuangding Hospital in Yantai, China. Food and Drug Administration (FDA) approved the first GBCA in 1998, and ever since, this class of drugs has been used with MRI to diagnose disease.

Education 105
article thumbnail

Dartmouth event bats around promise, shortcomings of AI in healthcare

AuntMinnie

Langlotz's laboratory investigates the use of deep neural networks and other machine-learning technologies to detect disease and eliminate diagnostic errors through analysis of medical images and clinical notes. Photo courtesy of Dartmouth.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PET/CT shows promise detecting early atherosclerosis

AuntMinnie

Shiv Patil, a student and researcher from the University of Pennsylvania, presented an F-18 NaF-PET/CT study that found the approach visualized biologically active vascular microcalcification in patients at early stages of the disease versus healthy volunteers.

article thumbnail

Can MRI Diagnose Dementia?

The Radiology Clinic

Can MRI diagnose dementia? The truth is that MRI is NOT the test to formally diagnose dementia. The truth is that MRI is NOT the test to formally diagnose dementia. Alzheimer’s disease is the most common and well known rendition of dementia, but there are other forms of the disease as well.

article thumbnail

Cryoablation safe and effective for treating breast cancer

AuntMinnie

In patients with breast cancer who underwent cryoablation with locally curative intent despite being ineligible for cryoablation clinical trials, such treatment had a low frequency of adverse events, and a high frequency of procedural technical success,” Oueidat and colleagues wrote. at one, two, and three years, respectively.

Disease 81
article thumbnail

ConcertAI's TeraRecon, Integrates Clinical and Generative AI, Supporting Clinical Research and Advancing Clinical Care Solutions at RSNA23

Imaging Technology

milla1cf Mon, 11/27/2023 - 14:13 November 27, 2023 — ConcertAI 's TeraRecon , the advanced visualization and clinical AI leader, recently unveiled first-in-category capabilities in advanced visualization, AI, and expansions to its AI partner ecosystem to enhance research capabilities and support complex clinical study workflows.

Clinic 52
article thumbnail

Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

Imaging Technology

Specifically, this sub-group examined the performance of flotufolastat F 18 PET in newly diagnosed, high-risk prostate cancer patients who had negative results with conventional imaging. Such information can help guide treatment selection and potentially avoid futile surgery for patients with high-risk disease.” “We